GWAS Seminar Series: Next-Gen GWAS. Now.

Up to 50% more coverage of common and rare variants. Maximum power for any population. Multiple product paths and flexible points of entry. Always the latest content. It's Next-gen GWAS with the whole genome in mind. At this seminar series, learn how the Omni family of microarrays can empower you to reach your ultimate research goals. Listen in as Illumina Scientists update you on the latest in genotyping technologies and a colleague reviews their results from an Illumina Infinium project.

When Sep 23, 2010
from 03:00 PM to 05:00 PM
Where MBRB Auditorium G202
Contact Name
Contact Phone 919-381-7278
Add event to calendar vCal
iCal


SEMINAR SCHEDULE


3:00PM- Introduction

3:05 PM- Next Generation GWAS: Delivering Content to Understand the Impact of Rare Variation to Disease

Carsten Rosenow, Ph.D., Illumina; Associate Director for Global Market Development for Genotyping Products

Building upon the HapMap Project, massive resequencing efforts, such as the 1000 Genomes Project, are delivering a catalogue of human variation at an unprecedented scale. These data are already offering a much richer understanding of the true spectrum of genetic variation across human populations. Illumina will provide this novel content as part of its 2010 Omni Product Roadmap by leveraging proven intelligent tagSNP selection and the ability to type up to 5 million markers per sample with allele frequencies down to 1%, delivering the power needed to fuel new genetic discoveries and enable an expanded understanding of how common and rare genetic variations contributes to human health and disease.
 

3:55 PM- SNP-Trait Associations in Filipino Young Adults Genotyped on the Illumina Cardio-Metabo Chip

Damien Croteau-Chonka, 4th year Ph.D. student in Genetics & Molecular Biology, UNC CH, Mohlke Lab

The Cardio-Metabo BeadChip is the result of an iSelect Consortium
project and is specifically designed to interrogate 200K markers of
interest to researchers studying the genetics of cardiovascular and
metabolic diseases in humans.

4:10 PM- Custom Genotyping Options from Illumina

Brent Anderson, M.S., Illumina; Southeast Technical Specialist

A broad portfolio of flexible products for custom genotyping supports multiplex assays from 48 to 200,000+ and facilitates even high throughput processing of hundreds of samples per day if required, for any organism.

4:30 PM- Q&A
5:00 PM- Conclusion

Register now at:

www.illumina.com


Please contact Jim Parina, your local Illumina Account Manager, with questions at
jparina@illumina.com or 919-381-7278 with questions.